Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan

Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, Zhijun Zhou, Yong Xie, Taojing Li, Junzheng Wu, Fengping Lu, Lu Feng, Min Mao, Lianzhen Lin, Huanhuan Guo, Shenglan Yue, Feifei Wang, Yan Peng, Yong Hu, Zejun Wang, Jianhong Yu, Yong Zhang, Jia Lu, Haoran Ning, Huichuan Yang, Daoxing Fu, Yanlin He, Dongbo Zhou, Tao Du, Kai Duan, Demei Dong, Kun Deng, Xia Zou, Ya Zhang, Rong Zhou, Yang Gao, Xinxin Zhang () and Xiaoming Yang ()
Additional contact information
Cesheng Li: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Ding Yu: Chengdu Rongsheng Pharmaceuticals Co., Ltd
Xiao Wu: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Hong Liang: Chengdu Rongsheng Pharmaceuticals Co., Ltd
Zhijun Zhou: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Yong Xie: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Taojing Li: Beijing Tiantan Biological Products Co., Ltd
Junzheng Wu: Chengdu Rongsheng Pharmaceuticals Co., Ltd
Fengping Lu: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Lu Feng: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Min Mao: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Lianzhen Lin: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Huanhuan Guo: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Shenglan Yue: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Feifei Wang: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Yan Peng: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Yong Hu: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Zejun Wang: Wuhan Institute of Biological Products Co. Ltd
Jianhong Yu: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Yong Zhang: Beijing Tiantan Biological Products Co., Ltd
Jia Lu: Wuhan Institute of Biological Products Co. Ltd
Haoran Ning: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Huichuan Yang: China National Biotec Group Company Limited
Daoxing Fu: Beijing Tiantan Biological Products Co., Ltd
Yanlin He: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Dongbo Zhou: Beijing Tiantan Biological Products Co., Ltd
Tao Du: Beijing Tiantan Biological Products Co., Ltd
Kai Duan: Wuhan Institute of Biological Products Co. Ltd
Demei Dong: Beijing Tiantan Biological Products Co., Ltd
Kun Deng: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Xia Zou: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Ya Zhang: Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd
Rong Zhou: Beijing Tiantan Biological Products Co., Ltd
Yang Gao: Beijing Tiantan Biological Products Co., Ltd
Xinxin Zhang: Shanghai Jiao Tong University of Medicine
Xiaoming Yang: China National Biotec Group Company Limited

Nature Communications, 2021, vol. 12, issue 1, 1-1

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-021-25109-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25109-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-021-25109-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().